Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.
- DOI
- 10.1016/s1473-3099(25)00721-2
- Published
- 2026-01-22
- Container
- Lancet Infect Dis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-25-00721-2,
title = {Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.},
author = {Louie T and Ribble W and Boccumini L and Johnson K and De Groote MA and Day J and Mason C and Sun X and Freeman J and Gu K and Tillotson G and Wilcox MH and Janjic N and Jarvis TC and Nayak SU and Ochsner UA and Bruss JB.},
year = {2026},
journal = {Lancet Infect Dis},
doi = {10.1016/s1473-3099(25)00721-2},
url = {https://doi.org/10.1016/s1473-3099(25)00721-2}
}RIS
TY - JOUR TI - Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study. AU - Louie T AU - Ribble W AU - Boccumini L AU - Johnson K AU - De Groote MA AU - Day J AU - Mason C AU - Sun X AU - Freeman J AU - Gu K AU - Tillotson G AU - Wilcox MH AU - Janjic N AU - Jarvis TC AU - Nayak SU AU - Ochsner UA AU - Bruss JB. PY - 2026 JO - Lancet Infect Dis DO - 10.1016/s1473-3099(25)00721-2 UR - https://doi.org/10.1016/s1473-3099(25)00721-2 ER -
APA
T, L., W, R., L, B., K, J., MA, D. G., J, D., C, M., X, S., J, F., K, G., G, T., MH, W., N, J., TC, J., SU, N., UA, O., & JB., B. (2026). Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.. Lancet Infect Dis. https://doi.org/10.1016/s1473-3099(25)00721-2
Source records
- europe-pmc · retrieved 2026-09-26T20:01:27.036Z